Skip to main content
RYTM
NASDAQ Life Sciences

Shares Jump 28% on Reported $124/Share AstraZeneca Bid; NICE Expands IMCIVREE Access

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$109.75
Mkt Cap
$7.621B
52W Low
$74.5
52W High
$122.2
52W Position info
47% above low
Off High info
10% below high
Rel. Volume info
6.6× avg
Market data snapshot near publication time

RYTM sits 47% above its 52-week low of $74.5 on elevated volume (6.6× avg).

Summary

Rhythm shares rose 28% to $110.68 after a report that AstraZeneca offered about $124 per share, valuing the company at roughly $10 billion. Neither firm confirmed the report, so the entire move rests on an unconfirmed press account. The stock still trades well below the reported offer, which tells you the market is discounting the odds of a deal getting done. Separately, NICE expanded IMCIVREE guidance to cover adults with genetically confirmed Bardet-Biedl syndrome in England, Wales and Northern Ireland, enabling NHS-funded treatment — a real commercial expansion on top of the August UK authorization. This lands days after the $855 million LG Chem license-out and Q3 revenue of $92.1 million, up 80% year over year, so the fundamental story was already improving before the bid report.

At the time of this announcement, RYTM was trading at $109.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $74.50 to $122.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

RYTM - Latest Insights

RYTM
Nov 16, 2026, 4:00 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $107.31
Real-time Price: $113.50 info
Change: +$6.19 (+6%) info
Market Cap: $7.79B info
RYTM
Nov 06, 2026, 11:06 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $109.39
Real-time Price: $113.50 info
Change: +$4.11 (+4%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 3:57 PM EST
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $95.21
Real-time Price: $113.50 info
Change: +$18.29 (+19%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $85.70
Real-time Price: $113.50 info
Change: +$27.80 (+32%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $88.42
Real-time Price: $113.50 info
Change: +$25.08 (+28%) info
Market Cap: $7.79B info